Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

2390results about How to "Improve bioavailability" patented technology

Probiotic microcapsule with function of improving intestinal microecology and key technology

The invention relates to the technical field of biological pharmacy, and discloses a probiotic microcapsule with a function of improving intestinal microecology, which comprises the following components in percentage by weight: lactobacillus rhamnosus: each gram of formula contains 1010 CFU of lactobacillus rhamnosus; lactobacillus acidophilus: each gram of the formula contains 109 CFU; clostridium butyricum: each gram of the formula contains 108 CFU; 5%-8% of a nano sodium alginate-chitosan compound; 3%-5% of peptide nanoparticles; 2%-4% of a natural polymer intelligent response film; 3%-6% of arabinoxylan oligosaccharide; 4%-7% of resistant dextran; 2%-4% of lentinan; and 0.1%-0.3% of resveratrol. Through a double-layer or three-layer embedding technology of the nano sodium alginate-chitosan compound and the intelligent response polymer film, the tolerance of the probiotics in gastric acid and cholate environments is remarkably enhanced, and targeted release of the probiotics in small intestines and colon is ensured.
Owner:HENAN BUSINESS SCI RES INST

Ginsenoside Rg3 nano-liposome easier to transdermally absorb as well as preparation method and application of ginsenoside Rg3 nano-liposome

The invention discloses a ginsenoside Rg3 nano-liposome easier for transdermal absorption as well as a preparation method and application thereof, and belongs to the technical field of liposome preparation. The ginsenoside Rg3 nano-liposome easier to transdermally absorb, provided by the invention, is prepared from the following raw materials in parts by mass: 5 to 20 parts of polyhydric alcohol, 2 to 10 parts of ginsenoside Rg3, 1 to 8 parts of phospholipid, 1 to 5 parts of cholesterol, 1 to 2 parts of resveratrol, 0 to 2 parts of a compound functional substance and 1 to 5 parts of water. The ginsenoside Rg3 nano-liposome easier to transdermally absorb, provided by the invention, has excellent anti-oxidation and anti-inflammatory characteristics through a compound synergistic effect of all the components, can regulate the skin state, comprehensively protect the skin from being damaged by free radicals and inflammation, solves the skin problem caused by external stimulation, and has a good application prospect. The skin care composition has the effects of protecting skin, maintaining skin barrier function, improving skin redness and improving skin stability, can be compounded with any skin care preparation for use, and has wide market application prospect.
Owner:WANSU (GUANGZHOU) BIOPHARMACEUTICAL CO LTD

Preparation method of lipidosome containing hair-growing active ingredients

The invention provides a preparation method of lipidosome containing hair-growing active ingredients, and belongs to the technical field of hair-growing products. According to the invention, active substances are utilized to regulate hormone level, improve scalp blood circulation, stimulate anti-hair loss factors and promote hair growth in multiple directions, and lipidosome formed by lecithin and oil-soluble active ingredients as raw materials is utilized to integrally entrap the active substances, so that the anti-hair loss effect is improved. The defect of weak transdermal ability caused by large water solubility difference among the active substances is overcome, the stability and bioavailability of the active substances can be improved, and the hair growth and development effects of the prepared lipidosome containing the hair growth active components are remarkably improved.
Owner:BOHUI MEICUI BIOENGINEERING TECH (GUANGDONG) CO LTD

Compound DOTA-HX2-DZ and application thereof

The invention provides a compound DOTA-HX2-DZ and application thereof, and belongs to the technical field of biological medicine. According to the invention, the molecular structure of DZ-HX2-DOTA is optimized, and a special connexon is designed and adopted, so that the problem of limited anti-tumor curative effect caused by poorer stability, fat solubility, tumor residence time and other properties of a radiolabeled drug in the prior art is solved. The compound provided by the invention can significantly reduce the risk of label removal of radioactive metal ions in an in-vivo environment, and ensures that the compound stably plays a role at a targeted part; the compound has excellent molecular lipid solubility, can penetrate cell membranes and vascular barriers more easily, improves the bioavailability of drugs, prolongs the in-vivo circulation time, prolongs the tumor residence time, and further improves the treatment efficiency. The DZ-HX2-DOTA disclosed by the invention has broad-spectrum tumor targeting property, and can be used for diagnosing and treating various types of malignant tumors.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV

Difunctional cavings oligopeptide GK-8 for preventing and treating metabolic syndrome and improving immunity

The invention discloses a bifunctional cavings oligopeptide GK-8 for preventing and treating metabolic syndrome and improving immunity and application of the bifunctional cavings oligopeptide GK-8. The amino acid sequence of the cavings oligopeptide is Gly-Leu-Ser-Phe-Asp-Phe-Tyr-Lys (GLSFDFYK, called GK-8 for short). Experiments find that the GK-8 has the effects of preventing and treating the metabolic syndrome of the mice, specifically, the GK-8 can obviously reduce the body weight of the mice, improve fatty degeneration and obviously reduce insulin resistance of the mice; the levels of triglyceride TG, total cholesterol TC and low-density lipoprotein LDL-C in mouse serum are obviously reduced, and the level of high-density lipoprotein HDL-C is increased; meanwhile, it is found that the GK-8 significantly activates the immunoregulation ability of an immunosuppressive mouse induced by cyclophosphamide, for example, the weight, thymus index and spleen index of the immunosuppressive mouse are recovered; the multiplication capacity of T lymphocytes and B lymphocytes of the spleen of the mouse, the killing activity of NK cells and the like are enhanced. The bran oligopeptide GK-8 is expected to be further researched and developed into related medicine products for preventing and treating the metabolic syndrome and improving the immunity, and the bran oligopeptide GK-8 has a wide application prospect.
Owner:SHANXI UNIV

Crystal form of heterocyclic compound and pharmaceutical composition thereof

The invention belongs to the field of medical chemistry, and particularly relates to a crystal form of a heterocyclic compound and a pharmaceutical composition thereof. Specifically, the invention relates to a crystal form of 4-((2R, 3S, 5R)-3-(3, 4-difluoro-2-methoxyphenyl)-5-methyl-5-(trifluoromethyl) thiacyclopentane-2-formamido) pyridine-2-formamide and a pharmaceutical composition of the crystal form of 4-((2R, 3S, 5R)-3-(3, 4-difluoro-2-methoxyphenyl)-5-methyl-5-(trifluoromethyl) thiacyclopentane-2-formamido) pyridine-2-formamide. The crystal form is good in crystallinity, excellent in chemical stability and crystal form stability, high in process safety and capable of playing a good drug effect in various animal models.
Owner:SICHUAN KELUN PHARMA RES INST CO LTD

Targeting exosome capable of delivering nucleic acid drugs and preparation method thereof

The invention relates to the technical field of biological medicine, and provides a targeting exosome capable of delivering nucleic acid drugs and a preparation method of the targeting exosome. The exosome comprises a fusion polypeptide, the fusion polypeptide comprises a targeting protein molecule, an exosome transmembrane protein and a nucleic acid binding domain, and the exosome can load a nucleic acid molecule through binding of the nucleic acid binding domain. According to the invention, engineering modification is carried out on the exosome, so that nucleic acid molecules can be efficiently loaded into the exosome, and meanwhile, the exosome is endowed with the capability of targeting to specific target cells, tissues and organs.
Owner:P S K BIOSCIENCE CO LTD

Soaking solution for corneal contact lens, preparation method and corneal contact lens

The invention provides a soak solution for a corneal contact lens, a preparation method of the soak solution and the corneal contact lens, and the soak solution is mainly prepared from the following raw materials in percentage by mass: 0.01%-0.15% of litamilast, 0.01%-0.15% of sodium dodecyl benzene sulfonate, 0.01%-0.15% of sodium dodecyl benzene sulfonate and the balance of water. 0.1%-2% of buffer salt; 0.2%-1.2% of sodium chloride; 0-0.5% of sodium thiosulfate; and 97%-99% of purified water. The soak solution for the corneal contact lens prepared by the invention can well interact with water molecules in the corneal contact lens, so that drug molecules in the soak solution are well replaced in the corneal contact lens, and the drug molecules are retained in a gel network of the corneal contact lens; the bioavailability of the medicine is improved while high medicine loading capacity is realized, and the corneal contact lens prepared from the soak solution has the effect of slowly releasing the medicine, directly acts on eyes and can reduce the toxic and side effects of the medicine.
Owner:SHANGHAI MODERN PHARMACEUTICAL ENGINEERING RESEARCH CENTER CO LTD

Pulsatilla saponin B4-oleanolic acid self-assembled nanoparticles as well as preparation and application thereof

The invention discloses pulsatilla saponin B4-oleanolic acid self-assembled nanoparticles as well as preparation and application thereof, and relates to the technical field of pharmaceutical preparations. Inspired by compatibility and solubilization of traditional Chinese medicines, the pulsatilla saponin B4-oleanolic acid self-assembled nanoparticles (AB4-OA NPs) are prepared by taking natural active components, namely micromolecular pulsatilla saponin B4 and oleanolic acid, as raw materials; the oleanolic acid has the effects of promoting dissolution and resisting inflammation, the water solubility of the oleanolic acid is improved, the bioavailability is improved, and the anti-inflammatory effect of the oleanolic acid is enhanced. Experimental results show that the AB4-OA NPs can effectively improve the dissolution rate of the oleanolic acid, so that the bioavailability of the oleanolic acid is effectively improved, meanwhile, the AB4-OA NPs has a better anti-inflammatory effect, and the effect is better than that of a single drug with the same dosage. In addition, the synthetic preparation method is simple and convenient, has the advantages of nano-scale drugs, realizes auxiliary-material-free pure drug self-delivery, and improves the delivery efficiency.
Owner:SOUTH CHINA AGRICULTURAL UNIVERSITY

Medical nutritional composition for promoting wound repair and preparation method thereof

The invention provides a medical nutritional composition for promoting wound repair. Comprising the following components in parts by weight: 10-15 parts of whey protein powder, 5-15 parts of soybean protein peptide powder, 5-10 parts of cattle spleen peptide powder, 10-15 parts of collagen tripeptide powder, 5-8 parts of collagen peptide powder, 10-12 parts of wheat oligopeptide powder, 5-10 parts of blood protein oligopeptide powder, 40-55 parts of low-GI compound carbohydrate, 3-7 parts of fat, 5-15 parts of compound plant extract, 0.2 part of vitamin C, 0.001 part of vitamin A and 0.015 part of vitamin E, the traditional Chinese medicine composition comprises the following components in parts by weight: 0.0018 parts of vitamin B1, 0.0018 parts of vitamin B2, 0.0015 parts of vitamin B6, 0.000002 parts of vitamin B12, 2-4 parts of hyaluronic acid, 10-18 parts of traditional Chinese medicine components and 1 part of inorganic salt combination package. The medical nutritional composition for promoting wound repair has the outstanding effects of more scientifically and comprehensively enhancing nutrition, reducing infection risk, improving immunity of patients and promoting the wound repair process.
Owner:YIRUN HEALTH IND (GUANGZHOU) CO LTD

Bacterial surface modification method based on atom transfer radical polymerization reaction mediation, modified bacteria and application of modified bacteria

The invention discloses a bacteria surface modification method based on atom transfer radical polymerization reaction mediation, obtained bacteria and application. The modification method comprises the following steps: carrying out acryloylation on the surfaces of the bacteria by using N-hydroxysuccinimide acrylate, and introducing double bonds on the surfaces of the bacteria to obtain acryloylated bacteria; the method comprises the following steps: by taking acrylamide, N-(3-aminopropyl) methacrylamide hydrochloride and N, N '-methylene bisacrylamide as monomers, carrying out polymerization reaction on the surfaces of acrylated bacteria in the presence of an initiator and a catalyst; the mass ratio of the acrylamide to the N-(3-aminopropyl) methacrylamide hydrochloride to the N, N '-methylene bisacrylamide is (11.9 to 17.5) to (0.125 to 1) to (0.1 to 0.5). According to the method, bacteria can be camouflaged to reduce immunogenicity and pathogenicity of the bacteria, the safety of bacteria treatment is improved under the condition that the viability and multiplication capacity of the bacteria are not affected, the resistance of the bacteria to environmental threats is enhanced, and the bacteria are endowed with no exogenous functions.
Owner:ANHUI MEDICAL UNIV

Freshwater fish flavored pet flavoring agent and production method thereof

The invention relates to the technical field of flavor agents, and provides a freshwater fish flavor pet flavor agent and a production method thereof, and the freshwater fish flavor pet flavor agent comprises the following components: freshwater fish, an enzyme preparation, reducing sugar, vitamins, amino acids, auxiliary materials and a herbaceous plant aqueous extract. Through scientific raw material selection, enzymic preparation proportion control, multi-element reducing sugar matching, comprehensive vitamin combination, balanced amino acid screening, herbaceous plant aqueous extract addition, nanotechnology wrapping operation and careful adjustment of auxiliary materials, the pet flavoring agent has the effects of special fragrance, rich taste, good palatability, immunity enhancement and the like.
Owner:BEIJING CENT BIOLOGY CO LTD +2

Nasal gel for treating allergic rhinitis and preparation method thereof

The invention discloses a nasal gel for treating allergic rhinitis and a preparation method thereof, and relates to the technical field of medicines. The nasal gel for treating allergic rhinitis is prepared from double-sensitive double-network drug-loaded gel microspheres and a temperature-sensitive gel material, the double-sensitive double-network drug-loaded gel microspheres are prepared from sodium alginate, a temperature-sensitive polymer, lactoferrin, a traditional Chinese medicine extracting solution and calcium chloride, the temperature-sensitive gel material is prepared from silk fibroin, carboxymethyl chitosan, K-carrageenan and genipin; the double-sensitive double-network drug-loading gel microspheres are loaded in the temperature-sensitive gel material, and after the temperature-sensitive gel material enters the nasal cavity, the temperature-sensitive gel material is quickly converted into gel to be adhered to nasal cilia, so that the removal of the double-sensitive double-network drug-loading gel microspheres by the motion of the nasal cilia is reduced, and the gel microspheres can better release a double-layer drug-loading system; the acting time of the medicine in the nasal cavity is prolonged, the bioavailability of the medicine is improved, the allergic rhinitis is effectively treated, and uncomfortable symptoms are relieved.
Owner:BEIJING CIMINGTANG MEDICAL RES INST

Atorvaquone enteric-coated tablet for dogs and preparation method thereof

The invention discloses an atorvaquone enteric-coated tablet, the preparation comprises atorvaquone, glyceryl behenate, teloxpol, a filler, an adhesive, a disintegrating agent and an enteric coating, and the particle size D90 of the atorvaquone is 30-50 [mu] m. The atorvaquone enteric-coated tablet disclosed by the invention is stable and continuous in release and high in bioavailability, can be positioned and released in intestinal tracts and reduce liver circulation, so that the occurrence of phenomena such as liver injury is reduced, the phenomena such as sticking and cracking are avoided in a tabletting process, the quality is qualified and stable, and the dissolution performance and the stability of the atorvaquone enteric-coated tablet are also ensured.
Owner:BEIJING CENT BIOLOGY CO LTD

Polypeptide metal chelate and application thereof in field of cosmetics

The invention relates to the field of polypeptide compositions, in particular to a polypeptide metal chelate and application thereof in the field of cosmetics, and the polypeptide metal chelate is formed by chelating a polypeptide compound and a metal ion compound. The structure of the polypeptide compound is [gamma-Glu] n-AA, n is greater than or equal to 1, and AA is selected from glycine, alanine, valine, leucine, isoleucine, methionine (methionine), proline, tryptophan, serine, tyrosine, cysteine, phenylalanine, asparagine, glutamine, threonine, asparaginic acid, glutamic acid, lysine, arginine or histidine; the polypeptide chelated zinc prepared by the invention has remarkable oil control and anti-inflammatory effects, and can be compounded with other raw materials to form cosmetics with oil control and acne removal effects.
Owner:WIJ HEALTHCARE (SHANGHAI) LTD

Tilmicosin premix and preparation method thereof

The invention belongs to the technical field of veterinary preparations, and particularly relates to a tilmicosin premix and a preparation method thereof. The tilmicosin premix is prepared from the following raw materials: tilmicosin, a polylactic acid-glycolic acid copolymer, lecithin, modified hydroxypropyl methyl cellulose, grafted polyvinylpyrrolidone, polyethylene glycol and an antioxidant, a solid dispersion is formed through lecithin and grafted polyvinylpyrrolidone, the solubility and stability of tilmicosin are enhanced, polylactic acid-glycolic acid copolymer nano-microspheres are prepared through a double-emulsion solvent evaporation method, slow release of drugs is achieved, dodecyl modified hydroxypropyl methyl cellulose and polyethylene glycol are combined, and the sustained release effect is achieved. The solubility and the slow release characteristic are further enhanced. The activity of the granular premix is effectively preserved, and the granular premix is convenient to use and transport.
Owner:SHANGHAI TONGREN PHARM CO LTD

Preparation method and application of drug delivery system based on hollow mesoporous polydopamine nanoparticles

The invention belongs to the field of drug preparation, and particularly relates to a preparation method and application of a drug delivery system based on hollow mesoporous polydopamine nanoparticles. The drug delivery system comprises hollow mesoporous polydopamine nanoparticles, a drug loaded inside and / or outside the hollow mesoporous polydopamine nanoparticles, and pectin wrapping the hollow mesoporous polydopamine nanoparticles, the medicine is a medicine with a nerve protection effect and an acetylcholin esterase inhibitor. The drug delivery system can reduce proinflammatory cytokines, regulate functions of target immune cells, synergistically reduce necrosis of neurons in intestinal tracts and induce neural crest stem cells in the intestinal tracts to be differentiated into neurons.
Owner:NANJING TECH UNIV

Eutectic microcapsule wrapping technology and application thereof in cosmetics

ActiveCN119112677AAntioxidant is goodGood soothing and anti-allergicCosmetic preparationsToilet preparationsPolymer scienceEthyl palmitate
The invention relates to a eutectic microcapsule wrapping technology and application thereof in cosmetics, and belongs to the technical field of cosmetic production. The wall material of the eutectic microcapsule inclusion comprises at least one of hydrogenated lecithin, caprylic / capric triglyceride, sucrose stearate, PEG-8 caprylic / capric glycerides, PEG-40 hydrogenated castor oil, soya bean lecithin, cyclodextrin, ethyl palmitate and troxerutin. The core material is prepared from at least one of salicylic acid, 4-butylresorcinol, glabridin, a kava extract, cortex magnoliae officinalis total phenols, ginseng oil, ganoderma lucidum spore oil, astaxanthin, coenzyme Q-10, a rosemary extract, ceramide and vitamin E. According to the invention, multiple eutectic coating can be formed, the consumption of the wall material can be reduced, the cost is saved, the wall material and the core material are matched for use, so that the excellent effects of permeation, oxidation resistance, soothing, allergy resistance and skin repair can be achieved, and the utilization rate of active substances is increased.
Owner:GUANGZHOU GAOTAI BIOTECHNOLOGY CO LTD

Pellet type buccal cigarette and preparation method thereof

The invention discloses a pellet type buccal cigarette and a preparation method thereof. The preparation method comprises the following steps: S1, preparing the spraying liquid from the adhesive, the nicotine salt, the pH regulator, the sweetening agent, the cooling agent and the essence. And S2, based on combination of centrifugal granulation and fluidization, performing coating treatment on the medicinal pill core by using a spraying liquid to obtain a wet pill. S3, the wet pellets are subjected to sieving treatment, and pellet particles with the particle size ranging from 300 micrometers to 1500 micrometers are obtained. And S4, drying the pellet particles, and bagging to obtain the buccal cigarette product. The prepared buccal cigarette product is high in quality, the discomfortableness caused by too high nicotine release speed is overcome, the problems that fragrance is poor in release uniformity, short in release time and prone to deterioration are solved, and the buccal cigarette has the advantages of being comfortable in taste, small in irritation to the mouth, good in fragrance uniformity and good in sensory experience and has excellent popularization prospects.
Owner:SHENZHEN HUAJIA BIOLOGICAL TECH

Targeting chimera based on cationic polymer protein hydrolysis as well as preparation and application of targeting chimera

The invention discloses a cationic polymer-based proteolysis targeting chimera as well as preparation and application thereof, and belongs to the fields of targeting protein degradation and nanotechnology. According to the chimera, a cationic polymer is used as a connecting arm to connect a target protein ligand and an E3 ubiquitin ligase ligand to form a ternary complex, so that efficient degradation of target protein is realized. By adjusting the ligand proportion, chimeras with different degradation efficiencies can be synthesized, and accurate regulation and control are realized. The pH-responsive nano-drug obtained by hydrolyzing the targeting chimera by using the targeting protein can respond to an acidic tumor microenvironment, specifically release the chimera, and improve the targeting property and the treatment effect of the drug. Compared with the traditional PROTACs, the compound has higher bioavailability and tumor permeation effect; the preparation method of the nano-drug is simple and easy to implement, provides possibility for preparation of high-performance nano-drugs, shows potential in preparation of anti-tumor cell drugs, provides new thoughts and methods for tumor treatment, and has important clinical application value.
Owner:SHAANXI UNIV OF SCI & TECH

Polypeptide hydrogel based on oxidized ganoderan and application

The invention discloses polypeptide hydrogel based on oxidized ganoderan and application. The polypeptide hydrogel is simple in preparation method, rapid in gelling, good in stability and capable of resisting oxidation activity and inhibiting tyrosinase activity. The polypeptide hydrogel provides a physical barrier for the bioactive peptide, so that the influence of the gastrointestinal tract environment is overcome, 71% of polypeptide is released in the intestinal tract, the bioavailability of the peptide is improved, and the problem that the use condition of the polypeptide is limited is effectively solved.
Owner:ZHEJIANG UNIV OF TECH

Two-phase gel loaded with natural antioxidant as well as preparation method and application of two-phase gel

The invention discloses biphase gel loaded with natural antioxidants as well as a preparation method and application of the biphase gel. The biphase gel is obtained by mixing oil gel and hydrogel in a mass ratio of (20: 80)-(80: 20) through a physical effect, wherein the hydrogel is composed of a water-soluble natural antioxidant and a polysaccharide aqueous solution; the oleogel is composed of an oleogel agent, a fat-soluble natural antioxidant, a small molecule emulsifier and edible oil. According to the present invention, the water-soluble nutrients are loaded in the hydrogel, and the fat-soluble nutrients are loaded in the oil gel to prepare different types of the two-phase gel nutrient delivery systems simultaneously loading the hydrophilic and hydrophobic natural antioxidants so as to effectively improve the steady-state protection effect and the bioavailability of the nutrients.
Owner:JIANGNAN UNIV

Natural plant extract food antioxidant additive and preparation method thereof

PendingCN119073493AAvoid oxidation reactionsControl oxidative rancidity processFood preservationBiotechnologyXanthonoid
The invention relates to a natural plant extract food antioxidant additive and a preparation method thereof, the natural plant extract food antioxidant additive comprises a core material and a wall material, and the core material comprises the following components by mass: 10-20 parts of a polyphenol compound, 10-15 parts of a polysaccharide compound and 20-30 parts of a flavonoid compound. The preparation method comprises the following steps: mixing sodium alginate and a polysaccharide compound to prepare a polysaccharide microcapsule; mixing a polyphenol compound, a flavonoid compound and the polysaccharide micro-capsule, and dispersing with an emulsifier to obtain an emulsified dispersion liquid; and mixing a chitosan solution and a polylysine solution to obtain a mixed wall material solution, adding the mixed wall material solution into the emulsified dispersion liquid to prepare a microcapsule product, washing, and freeze-drying to obtain the food antioxidant additive of the natural plant extract. The additive has the effect of improving the anti-oxidation performance, can provide long-acting and lasting anti-oxidation protection, and has a certain health-care effect.
Owner:WUXI JIANGDA BAITAI TECH CO LTD

Nintedanib-loaded anti-adhesion membrane as well as preparation method and application thereof

The invention discloses an anti-adhesion membrane loaded with nintedanib and a preparation method of the anti-adhesion membrane loaded with the nintedanib. The anti-adhesion membrane loaded with the nintedanib is prepared from a drug-loading substrate material and the nintedanib through electrostatic spinning, the material of the drug-loading substrate is one or more of polylactic acid, poly (p-dioxanone), a polylactic acid-glycolic acid copolymer, polycaprolactone and polyethylene glycol; a solvent adopted in the electrostatic spinning is hexafluoroisopropanol, and the voltage adopted in the electrostatic spinning is 10-14 kV. The nintedanib-loaded anti-adhesion membrane has the advantages that the tensile strength and the elongation at break are obviously improved, the mechanical property is obviously improved, the fiber distribution is uniform, the obvious anti-adhesion effect is realized, the nintedanib-loaded anti-adhesion membrane is suitable for common laparotomy, and the application prospect is wide.
Owner:SOUTH CHINA UNIV OF TECH +1

Double-phase essence emulsified cup-sticking-free lipstick and preparation method thereof

The invention relates to the field of A61K8 / 18, in particular to a double-phase essence emulsified cup-sticking-free lipstick and a preparation method thereof.The double-phase essence emulsified cup-sticking-free lipstick is composed of an outer packing material and an inner material, and the packing material is one of an air-tight lipstick container, a slow-rotating lipstick container, a direct-filling lipstick container, a backward-filling lipstick container, a pressing pen lipstick container and a rotating pen lipstick container; the inner material at least comprises the following components in percentage by mass: 1%-30% of water-phase essence, 0.1%-10% of an emollient, 30%-70% of a high-refractive-index raw material, 0.1%-10% of an emulsifier, 5%-15% of wax, 0.01%-1.5% of a coloring agent, 0.1%-3% of an anticorrosive and antibacterial component, 0-5% of a defoaming agent and the balance of water; by optimizing a product formula system and matching with specific preparation and filling technologies, the lipstick is ensured to have excellent paste face, side and cup-sticking-free states, and the problems of cup sticking and inconvenience in use of an existing lipstick system are solved.
Owner:COSMAX CHINA INC

Acoustic / chemical power synergistic anti-tumor nano-drug as well as preparation method and application thereof

ActiveCN119113145Areduce hypoxiaspeed up progressOrganic active ingredientsInorganic active ingredientsVitamin CPeroxidase
The invention relates to the technical field of nano-drugs, in particular to an acoustic / chemical power synergistic anti-tumor nano-drug as well as a preparation method and application thereof. The invention provides an acoustic / chemical power synergistic anti-tumor nano-drug, which takes hollow mesoporous MnO2 nano-particles as a carrier, and is loaded with vitamin C and a sound-sensitive agent chlorin e6. Vc can generate abundant H2O2 to provide a raw material for CDT, and MnO2 is used as a peroxidase-like enzyme to catalyze H2O2 to generate O2, so that tumor hypoxia is effectively relieved, and the effect of sonodynamic therapy is enhanced. Besides, GSH induces MnO2 degradation, GSH consumption is caused to enhance CDT, GSH depletion can cause glutathione peroxidase 4 (GPX4) activity reduction, ROS generation and GPX4 activity reduction have a synergistic effect, lipid peroxides (LPOs) are increased, and finally ferroptosis of tumor cells is caused.
Owner:SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY (SHANDONG PROVINCIAL HOSPITAL)

Upatinib oral solution as well as preparation method and application thereof

The invention relates to the technical field of pharmaceutical preparations, in particular to an upatinib oral solution as well as a preparation method and application thereof. The oral upatinib solution is prepared from the following components in percentage by weight: 0.1%-1.5% of upatinib, 1%-20% of hydroxypropyl beta-cyclodextrin, 0.5%-5% of a flavoring agent and the balance of water, wherein the oral upatinib solution is prepared from the following components in percentage by weight: 0.1%-1.5% of upatinib, 1%-20% of hydroxypropyl beta-cyclodextrin, 0.5%-5% of a flavoring agent and the balance of water; the degree of substitution of the hydroxypropyl beta-cyclodextrin is 4.0 to 5.5. The oral upatinib solution overcomes the problems of overlarge tablet diameter, poor oral compliance, low solubility in water and low bioavailability of upatinib tablets in the prior art, and has the advantages of simplicity in preparation and convenience in use.
Owner:杭州和康药业有限公司

Uric acid-reducing apigenin cyclodextrin inclusion compound liposome and preparation method thereof

The invention discloses a uric acid reducing apigenin cyclodextrin inclusion compound liposome and a preparation method thereof. The uric acid reducing apigenin cyclodextrin inclusion compound liposome is prepared from the following components in parts by weight: 1 part of apigenin, 2 to 50 parts of beta-cyclodextrin, 0.8 to 30 parts of phospholipid and 0.1 to 10 parts of surfactant. According to the invention, apigenin is included in beta-cyclodextrin to obtain the apigenin cyclodextrin inclusion compound, and the water solubility of apigenin can be improved and the molecular volume can be increased through a cyclodextrin inclusion method to reduce the ability of apigenin to penetrate through a phospholipid bilayer; and the apigenin cyclodextrin inclusion compound is encapsulated in the liposome to obtain the apigenin cyclodextrin inclusion compound liposome, so that the stability of the liposome is fundamentally improved, and the problem of liposome drug leakage in a liquid state is solved. The whole water solubility of the apigenin cyclodextrin inclusion compound liposome provided by the invention is improved, the apigenin cyclodextrin inclusion compound liposome has good stability and slow release effect, the bioavailability of apigenin is improved, and the uric acid reducing effect is obviously superior to that of untreated apigenin.
Owner:XIAN NUOZHONGKANGJIAN BIOTECHNOLOGY CO LTD

Artificial exosome and application thereof in drug delivery

The invention relates to the technical field of medicine, and discloses an artificial exosome and application thereof in drug delivery, the artificial exosome is prepared into an oil phase based on PLGA and DOTAP, and a water phase based on OCT4 protein and siTrim28; mixing the two phases to obtain a primary emulsion, and adding a PVA aqueous solution to obtain a double emulsion; stirring the double emulsion and volatilizing the solvent to form an emulsified solution, and centrifuging to obtain PLGA nanoparticles; the lipid mixture is prepared from lipid, DPPE-PEG2000, alpha-tocopherol and alpha-lactalbumin, and a lipid film is formed after a solvent is evaporated; the preparation method comprises the following steps: mixing PLGA nanoparticles, a lipid film and membrane protein, uniformly mixing and heating to obtain a film-coated solution, and finally extruding through a cellulose acetate film to obtain the artificial exosome. The artificial exosome disclosed by the invention combines the stability of the PLGA nanoparticles and the biocompatibility of the lipid membrane, and provides new possibility for a drug delivery system.
Owner:GUANGZHOU MEDICAL UNIV +1

Oral mucosa administration sedation maintaining medicament and preparation method thereof

The invention belongs to the field of preparation of sedation maintaining agents, and particularly relates to a sedation maintaining agent administrated through oral mucosa and a preparation method of the sedation maintaining agent. Bamboo leaf polysaccharide and pigskin collagen peptide are heated and mixed with chlorogenic acid and butyl acetate under the catalytic action of lanthanum nitrate, and the obtained moisturizing adhesive has biocompatibility, can be stably adhered to oral mucosa and can promote salivary secretion of children; nanoparticles obtained through freeze spray drying are uniformly dispersed in a copolymer solution containing sodium salicylate and polyacrylate, and the obtained nervous system regulator can balance excitability of sympathetic nerves and parasympathetic nerves of children; the emotion relieving composition contains modified felwort powder obtained through esterification reaction, the modified felwort powder is mixed with a moisturizing adhesive and a nervous system regulator, and the prepared sedation maintaining medicament administrated through the oral mucosa protects oral health of children in the oral operation anesthesia process, is free of irritation, improves anxiety emotion and does not affect postoperative awakening.
Owner:FOSHAN DENTAL HOSPITAL